| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/14/2005 | EP1401432B1 Imidazole derivatives for modulating sodium channels |
| 09/14/2005 | EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 09/14/2005 | EP1258250B1 Nerve protective drugs |
| 09/14/2005 | CN1668618A Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof |
| 09/14/2005 | CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors |
| 09/14/2005 | CN1668595A Method of forming a carbon-carbon or carbon-heteroatom linkage |
| 09/13/2005 | US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis |
| 09/13/2005 | CA2292927C New imidazolin compounds, the process for preparing them and the pharmaceutical compositions that contain them |
| 09/09/2005 | WO2005082861A1 Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5-dimethylbenzoic acid or ester thereof |
| 09/09/2005 | WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof |
| 09/09/2005 | CA2556075A1 Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5-dimethylbenzoic acid or ester thereof |
| 09/08/2005 | US20050197377 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders |
| 09/08/2005 | US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents |
| 09/08/2005 | US20050196813 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 09/07/2005 | EP1569921A1 Ionic liquids comprising n(cf sb 3 /sb ) sb 2 /sb ] sp - /sp anions |
| 09/07/2005 | EP1569919A2 Non-nucleoside reverse transcriptase inhibitors |
| 09/07/2005 | EP1569915A2 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 09/07/2005 | CN1665793A Ionic liquids |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665500A Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 09/07/2005 | CN1217995C Method of colouring hair using cationic dyes |
| 09/07/2005 | CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same |
| 09/06/2005 | US6939974 Heating an imidazolium halide with a strong base under reduced pressure and separating the resultant products |
| 09/06/2005 | US6939967 Non-proteinogenic L-amino acids |
| 09/06/2005 | US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders |
| 09/06/2005 | CA2250395C Eprosartan dihydrate and a process for its production and formulation |
| 09/06/2005 | CA2127536C Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists |
| 09/01/2005 | WO2005080367A1 Ep2 receptor agonists |
| 09/01/2005 | WO2005080347A1 Novel imidazolium compound |
| 09/01/2005 | WO2005080346A1 Substituted azole derivatives, compositions, and methods of use |
| 09/01/2005 | WO2005080345A2 Imidazoline derivatives having cb1-antagonistic activity |
| 09/01/2005 | WO2005080322A1 Fluorene derivative |
| 09/01/2005 | WO2005079866A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 09/01/2005 | WO2005079865A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 09/01/2005 | WO2005079790A1 Imidazole-based hmg-coa reductase inhibitors |
| 09/01/2005 | WO2005041853B1 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines. |
| 09/01/2005 | WO2004054991A8 Ionic liquids comprising [n(cf3)2]- anions |
| 09/01/2005 | US20050192354 Such as N-alpha-(cyanoacetyl)-L-histidine; dipeptides |
| 09/01/2005 | US20050192347 Urea and thiourea compounds and compositions for cholesterol management and related uses |
| 09/01/2005 | US20050192330 Using 4-imidazoline carboxylic acid or ester; antiinflammatory agents; microbiocides; bactericides; antitumor agenst0 |
| 09/01/2005 | US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/01/2005 | US20050192231 Treating hepatitis with a cytoprotective agents such as benzyloxycarbonyl-valine-aspartic acid(methyl ester)-methyl fluoride or having leucine and isoleucine as replacements for valine; caspase enzyme inhibitors; fas antigen suppressors; neuroprotective agents; antiischemic agents; organ transplants |
| 09/01/2005 | CA2555963A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 09/01/2005 | CA2555959A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 09/01/2005 | CA2553372A1 Imidazoline derivatives having cb1-antagonistic activity |
| 09/01/2005 | CA2548218A1 Imidazole-based hmg-coa reductase inhibitors |
| 09/01/2005 | CA2537079A1 Fluorene derivative |
| 08/31/2005 | EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors |
| 08/31/2005 | EP1568367A1 Compounds effecting glucokinase |
| 08/31/2005 | EP1379485A4 Selective ring-opening cross-metathesis of cycloolefins |
| 08/31/2005 | EP1237875B1 Substituted imidazole neuropeptide y y5 receptor antagonists |
| 08/31/2005 | EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/31/2005 | EP1117424B1 Null igf for the treatment of cancer |
| 08/31/2005 | EP1003497B1 Il-8 receptor antagonists |
| 08/31/2005 | CN1662508A Compounds, compositions and methods |
| 08/31/2005 | CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma |
| 08/31/2005 | CN1660817A Alkaline amino acid salt of Glycididazole acid, preparation and application |
| 08/31/2005 | CN1660816A Method for synthesizing 2-perfluoroalkyl group substituted ramification of imidazole |
| 08/31/2005 | CN1660720A Method for producing molecular compound |
| 08/31/2005 | CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia |
| 08/31/2005 | CN1216870C Serine-histamine acidamine and its preparation method and application |
| 08/31/2005 | CN1216869C Polymorphic crystalline forms of celecoxib |
| 08/31/2005 | CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/30/2005 | US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents |
| 08/30/2005 | US6936677 Using isocyanate dimers, trimer for polyurethanes |
| 08/30/2005 | US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing |
| 08/30/2005 | US6936626 Retinoic acid mimetic anilides |
| 08/25/2005 | WO2005077913A1 Method for producing 4-nitroimidazole compound |
| 08/25/2005 | WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
| 08/25/2005 | WO2005007108A3 Asymmetric disulfides and methods of using same |
| 08/25/2005 | WO2004069394A3 Synthetic method for direct arylation of heterocyclic arenes |
| 08/25/2005 | US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction |
| 08/25/2005 | US20050187277 Protein tyrosine phosphatase inhibitors; diseases including type I and type II diabetes, cancer, autoimmune diseases, AIDS; imidazole, oxazole and thiazole derivatives; e.g. 4-(4-(2,4-dichloro-phenyl)-2-(2-(3'-methanesulfonyl-biphenyl-4-yl)-(E)-vinyl)-imidazol-1-ylmethyl)-benzoic acid |
| 08/25/2005 | US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation |
| 08/25/2005 | US20050187259 Imidazoline derivatives having CB1-antagonistic activity |
| 08/25/2005 | US20050187242 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases |
| 08/25/2005 | US20050187222 Therapy for impotency, erectile dysfuction; benign prostatic hyperplasia; hypotensive agents; congestive heart failure; vision defects; neurodegenerative disorders; incotinence; cognition activators |
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/25/2005 | US20050186263 PH-sensitive polymeric micelles for drug delivery |
| 08/25/2005 | DE102004006422A1 Novel imidazolium and imidazolidinium salts can be used as precursors for carbene ligands for use in the preparation of novel metal complexes useful as catalysts |
| 08/25/2005 | DE102004005404A1 Verfahren zur Herstellung von Guanidinium-Salzen A process for preparing guanidinium salts |
| 08/25/2005 | CA2555372A1 Method for producing 4-nitroimidazole compound |
| 08/24/2005 | EP1565472A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 08/24/2005 | EP1565445A1 Novel process for the preparation of imidazolyl compounds |
| 08/24/2005 | EP1565422A1 Vitamin d receptor modulators |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1451207A4 Labeling reagent and methods of use |
| 08/24/2005 | EP1280779B1 New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| 08/24/2005 | EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 08/24/2005 | CN1659156A Novel guanidinobenzamides |
| 08/24/2005 | CN1659136A Novel sodium channel blockers |
| 08/24/2005 | CN1216046C Improved methods of synthesis for 9-substituted hypoxanthine derivatives |
| 08/23/2005 | US6933391 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor |
| 08/23/2005 | US6933390 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate |
| 08/23/2005 | US6933304 Antitumor agents, osteoporosis |
| 08/18/2005 | WO2005075436A2 Novel inhibitors of glutaminyl cyclase |
| 08/18/2005 | WO2005075435A1 Modulators of atp-binding cassette transporters |